ICD Shock Management and Outcomes

Introduction to ICD Shocks

An ICD shock is a high-energy electrical current delivered by an implantable cardioverter-defibrillator to terminate life-threatening ventricular arrhythmias, which can be either appropriate or inappropriate, according to the American Heart Association 1, 2
The European Society of Cardiology states that ICDs can deliver therapy in two ways: high-energy shocks and antitachycardia pacing (ATP), which can painlessly terminate many ventricular tachycardias 2, 4

Appropriate shocks are delivered in response to life-threatening ventricular arrhythmias, such as ventricular tachycardia or ventricular fibrillation, and are potentially life-saving but can impact quality of life, as noted by the American College of Cardiology 1, 2
Inappropriate shocks are triggered by non-life-threatening conditions, including supraventricular tachycardias, and occur in approximately 30% of ICD patients, significantly impacting quality of life, according to the European Heart Journal 1, 6
ICD shocks can cause temporary myocardial injury, associated with temporary or permanent increase in stimulation threshold and potential impairment of ventricular function, as reported by the Journal of the American College of Cardiology 4, 7

Both appropriate and inappropriate shocks are associated with reduced quality of life, increased psychological distress, and higher mortality rates, as stated by the American Heart Association and the European Society of Cardiology 1, 4, 6
The American College of Cardiology recommends that patients experiencing recurrent appropriate shocks may be treated with antiarrhythmic medications, beta-blockers, or catheter ablation, while those with inappropriate shocks may require device reprogramming or electrophysiological study 1, 5, 6

The European Heart Journal suggests that device interrogation should be performed after shocks to determine if they were appropriate or inappropriate and guide management, and that modern programming strategies can reduce unnecessary shocks while maintaining protection against sudden death 5, 7
Subcutaneous ICDs (S-ICDs) are now available as an alternative to transvenous systems for patients who don't require pacing, as reported by the Journal of the American College of Cardiology, and require careful patient selection as they cannot provide bradycardia pacing or antitachycardia pacing 2, 5